Detection of Non-small cell Lung Cancer using Histopathological Images by the approach of Deep Learning

Dhurka Prasanna P, Janima K Radhakrishnan, Kurapati Sreenivas Aravind, Pranav Nambiar, Nalini Sampath
{"title":"Detection of Non-small cell Lung Cancer using Histopathological Images by the approach of Deep Learning","authors":"Dhurka Prasanna P, Janima K Radhakrishnan, Kurapati Sreenivas Aravind, Pranav Nambiar, Nalini Sampath","doi":"10.1109/CONIT55038.2022.9847945","DOIUrl":null,"url":null,"abstract":"“Lung cancer” is one of the most widely found cancers in the world, accounting for 2 million deaths in 2018 alone. It is still the leading cause of cancer worldwide. One of the most routine pathological diagnosis tasks for pathologists is the classification of cancer cells at the histopathological level. Histopathological images allow the pathologists to do an in-depth analysis of the cancer cells. A pathologist must evaluate the microscopic appearance of a “biopsied sample” based on morphological features that have been correlated with patient outcome in order to estimate the severity of a cancer. Since histopathological images provide a better understanding of the grade of the cancer, the dataset used in the articles are histopathological images. The model tries to harness the tremendous power of Artificial Intelligence to identify and classify lung cancer without the help of a pathologist. Knowing that pathologists are facing heavy workloads due to an increasing number of patients struggling with lung cancer, this model would be an appropriate fit for the medical industry. This model could also be used in regions that have a shortage of access to any Pathological center nearby. The output of our model will be the classification of the cancer image into malignant and benign cancer, and in the subsequent step, we hope we will be able to grade the cancer into its corresponding stage. The aim of the article is to do a comparative study between benign and malignant cancer cells.","PeriodicalId":270445,"journal":{"name":"2022 2nd International Conference on Intelligent Technologies (CONIT)","volume":"65 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"2022 2nd International Conference on Intelligent Technologies (CONIT)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1109/CONIT55038.2022.9847945","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

“Lung cancer” is one of the most widely found cancers in the world, accounting for 2 million deaths in 2018 alone. It is still the leading cause of cancer worldwide. One of the most routine pathological diagnosis tasks for pathologists is the classification of cancer cells at the histopathological level. Histopathological images allow the pathologists to do an in-depth analysis of the cancer cells. A pathologist must evaluate the microscopic appearance of a “biopsied sample” based on morphological features that have been correlated with patient outcome in order to estimate the severity of a cancer. Since histopathological images provide a better understanding of the grade of the cancer, the dataset used in the articles are histopathological images. The model tries to harness the tremendous power of Artificial Intelligence to identify and classify lung cancer without the help of a pathologist. Knowing that pathologists are facing heavy workloads due to an increasing number of patients struggling with lung cancer, this model would be an appropriate fit for the medical industry. This model could also be used in regions that have a shortage of access to any Pathological center nearby. The output of our model will be the classification of the cancer image into malignant and benign cancer, and in the subsequent step, we hope we will be able to grade the cancer into its corresponding stage. The aim of the article is to do a comparative study between benign and malignant cancer cells.
基于深度学习方法的组织病理学图像检测非小细胞肺癌
“肺癌”是世界上最常见的癌症之一,仅2018年就有200万人死亡。它仍然是全球癌症的主要原因。病理学家最常规的病理诊断任务之一是在组织病理水平上对癌细胞进行分类。组织病理学图像使病理学家能够对癌细胞进行深入分析。病理学家必须根据与患者预后相关的形态学特征来评估“活检样本”的显微外观,以便估计癌症的严重程度。由于组织病理学图像可以更好地了解癌症的等级,因此文章中使用的数据集是组织病理学图像。该模型试图利用人工智能的巨大力量,在没有病理学家帮助的情况下识别和分类肺癌。由于越来越多的患者与肺癌作斗争,病理学家面临着繁重的工作量,这种模式将非常适合医疗行业。该模型也可用于附近缺乏任何病理中心的地区。我们模型的输出将是将癌症图像分类为恶性和良性癌症,在接下来的步骤中,我们希望能够将癌症分级到相应的阶段。本文的目的是对良性和恶性癌细胞进行比较研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信